|
27.01.2025 08:47:46
|
Ultimovacs ASA: Invitation to fourth quarter 2024 results webcast presentation
Oslo, January 27, 2025: Ultimovacs ASA ("Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, invites to a webcast presentation of its fourth quarter 2024 results, on Friday, January 31, 2025.
The presentation can be followed as a live webcast accessed through a link on www.ultimovacs.com at 09:00 CET on Friday, January 31, 2025. The webcast presentation will be available on the Ultimovacs website, and it will be possible to post questions during the presentation through the webcast. Note that the webcast presentation has been rescheduled from February 13, 2025, due to the ongoing business combination with Zelluna Immunotherapy AS, in order to fulfill regulatory requirements associated with this process.
The report and presentation will be available on the company website from 07:00 CET the same day.
For further information, please see www.ultimovacs.com or contact:
Hans Vassgård Eid, CFO and Interim CEO, Ultimovacs ASA
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632
Analysen zu Ultimovacs AS Registered Shs
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
NEU✅ Meta Platforms
NEU✅ Microsoft
inklusive Rebalancing:
❌ Arthur J. Gallagher & Co
❌ Progressive
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| Ultimovacs AS Registered Shs | 2.08 | -3.26% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Wall Street gespalten -- SMI schliesst im Plus -- DAX zum Handelsende fester -- Börsen in Fernost letztlich uneinig - Nikkei stabilDer heimische und der deutsche Aktienmarkt präsentierten sich zur Wochenmitte freundlich. Die US-Börsen finden zur Wochenmitte keine gemeinsame Richtung. Auch die asiatischen Indizes gaben indes überwiegend nach, lediglich der Nikkei hielt sich knapp im Plus.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |